Ethnicity and prognosis in acute myeloid leukemia

American Journal of Hematology

Volumn 72, Issue 2, 2003, Pages 127-134

  Alcalai, Ronny ^a   Ben Yehuda, Dina ^a   Ronen, Ilana ^a   Paltiel, Ora ^a  

^a HADASSAH HEBREW UNIVERSITY MEDICAL CENTER   (Israel)

Author keywords

AML; Ethnicity; Prognosis; Social class; Survival

Indexed keywords

ACUTE GRANULOCYTIC LEUKEMIA; ACUTE LYMPHOCYTIC LEUKEMIA; ADOLESCENT; ADULT; AGED; ARAB; ARTICLE; BREAST CANCER; CANCER EPIDEMIOLOGY; CANCER SURVIVAL; CHILDHOOD CANCER; CHROMOSOME ABERRATION; CLINICAL FEATURE; COPING BEHAVIOR; DEMOGRAPHY; ETHNIC GROUP; EUROPE; FEMALE; HIGH RISK POPULATION; HUMAN; ISRAEL; JEW; LEUKOCYTE COUNT; MAJOR CLINICAL STUDY; MALE; MULTIVARIATE ANALYSIS; OUTCOMES RESEARCH; PATIENT COMPLIANCE; PRIORITY JOURNAL; PROGNOSIS; REMISSION; RISK ASSESSMENT; RISK FACTOR; SOCIAL ASPECT; SOCIOECONOMICS; STATISTICAL SIGNIFICANCE;

ACUTE DISEASE; ADOLESCENT; ADULT; AGED; ANALYSIS OF VARIANCE; ARABS; EUROPE; FEMALE; HUMANS; ISRAEL; JEWS; LEUKEMIA, MYELOID; MALE; MIDDLE AGED; PROGNOSIS; REMISSION INDUCTION; RETROSPECTIVE STUDIES; RISK FACTORS; SURVIVAL ANALYSIS; TREATMENT OUTCOME;

EID: 0037309570     PISSN: 03618609     EISSN: None     Source Type: Journal    
DOI: 10.1002/ajh.10270     Document Type: Article

References (28)

1. Bernard P, Reiffers J, Lacombe F, Dachary D, Boisseau MR, Broustet A. A stage classification for prognosis in adult AML based upon patient's age, bone marrow karyotype and clinical features. Scandinavian J Hematol 1984;32:429-437.
2. Buchner T, Heinecke A. The role of prognostic factors in acute myeloid leukemia. Leukemia 1996;10:S28-S29.
3. Leith CP, Chir MBB, Willman CL. Prognostic markers in acute leukemia. Curr Opin Hematol 1996;3:329-334.
4. Minden M, Imrie K, Keating A. Acute leukemia in adults. Curr Opin Hematol 1996;3:259-265.
5. Fenaux P, Preudhomme C, Lai L, Morel P, Beuscart R, Bauters F. Cytogenetics and their prognostic value in de novo acute myeloid leukemia: a report on 283 cases. Br J Hematol 1989;73:61-67.
6. Schiffer CA, Lee EJ, Tomiyasu T, Wiemik PH, Testa JR. Prognostic impact of cytogenetic abnormalities in patient with de novo acute nonlymphocytic Leukemia. Blood 1989;73(1):263-270.
7. Stasi R, Delpoeta G, Masi M, Tribalto M, Venditti A, Papa G, Nicoletti B, Vernole P, Tedeschi B, Delaroche I. Incidence of chromosome abnormalities and clinical significance of karyotype in de novo acute myeloid leukemia. Cancer Genet Cytogenet 1993;67:28-34.
8. Baider L, Sarell M. Perceptions and causal attributions of Israeli women with breast cancer conceming their illness: the effect of ethnicity and religiosity. Psychother Psychosom 1983;39(3):136-143.
9. Lethaby AE, Mason BH, Holdaway IM, Kay RG. Age and ethnicity as prognostic factors influencing overall survival in breast cancer patients in the Auckland region. N Z Med J 1992;105:485-489.
10. Perkins P, Cooksley CD, Cox JD. Breast cancer: is ethnicity an independent prognostic factor for survival? Cancer 1996;78:1241-1247.
11. Hord MH, Smith TL, Culbert SJ, Frankel LS, Pinkel DP. Ethnicity and cure rates of Texas children with acute lymphoid leukemia. Cancer 1996;77:563-569.
12. Kaplan EL, Meier P. Non-parametric estimation for incomplete observations. J Am Stat Assoc 1958;53:457-481.
13. Cox DR. Regression models and life tables (with discussion). J R Stat Soc 1972;34:187-202.
14. Faggiano F, Partanen T, Kogevinas M, Boffetta P. Socioeconomic differences in cancer incidence and mortality. IARC Scientific Publications. Lyon, France: IARC; 1997. Vol 138, Chap 5, pp 65-73.
15. Auvinen A, Karjalainen S, Pukkala E. Social class and cancer patient survival in Finland. Am J Epidemiol 1995;142:1089-1102.
16. Revesz T, Mpofu C, Oyejide C, Bener A. Socioeconomic factors in the families of children with lymphoid malignancy in the UAE. Leukemia 1997:11:588-593.
17. Statistical Abstract of Israel 2000. No. 51. Website: http://www. cbs.gov.il
18. Lamvik J, Dybedal I, Hammerstrom J, Waage A. Acute leukemia in middle Norway 1984-88. Leuk Lymphoma 1994;16:65-71.
19. Swansbury GJ, Lawler SD, Alimena G, Arthur D, Berger R, Van den Berghe H, Bloomfield CD, de la Chappelle A, Dewald G, Garson OM. Long-term survival in acute myelogeous leukemia: a second follow-up of the Fourth International Workshop on Chromosomes in Leukemia. Cancer Genet Cytogenet 1994;73:1-7.
20. Bloomfield CD, Lawrence D, Byrd JC, Carroll A, Pettenati MJ, Tantravahi R, Patil SR, Davey FR, Berg DT, Schiffer CA, Arthur DC, Mayer RJ. Frequency of prolonged remission duration after high-dose cytarabine intensification in acute myeloid leukemia varies by cytogenetic subtype. Cancer Res 1998;58(18):4173-4179.
21. Smooha S. Class ethnic and natural changes and democracy in Israel. In: Sprinza E, Diamond L, editors. Israel: democracy under stress. London: Lymma-Rienner; 1993. pp 309-342.
22. Manor O, Eisenbach Z, Israeli A, Friedlander Y. Mortality differentials among women: the Israel Longitudinal Mortality Study. Soc Sci Med 2000;51:1175-1188.
23. Goodman RM, Bonne-Tamir B, Adam A, Voss R, Bach G, Shiloh Y, Bat-Miriam Katzanelson M, Barkai G, Goldman B, Padeh B, Chemke J, Legum C. Medical genetics in Israel. J Med Genet 1989;26:179-189.
24. Zlotogora J, Chemke J. Medical genetics in Israel. Eur J Hum Genet 1995;3:147-154.
25. Auvinen A, Karjalainen S. Possible explanations for social class differences in cancer patient survival. IARC Scientific Publications. Lyon, France: IARC; 1997. Vol 138, Chap 20, pp 377-397.
26. Guralnic JM, Leveille SG. Annotation: race, ethnicity and health outcomes - unraveling the mediating role of socioeconomic status. Am J Publ Health 1997;87:728-730.
27. Bach PB, Cramer LD, Warren JL, Begg CB. Racial differences in the treatment of early stage lung cancer. New Engl J Med 1999;341:1198-1205.
28. King TE, Brunetta P. Racial disparity in rates of surgery for lung cancer. New Engl J Med 1999;341:1231-1233.